| http://www.w3.org/ns/prov#value | - Given the absence of genuine market conditions in many countries, Lilly is committed to engaging with governments and other parties to discuss principles and pragmatic public policy approaches that will enable the development of government pricing and reimbursement systems that reflect the value of products, include the patient perspective, and reward innovation.
|
